Dow Up0.91% Nasdaq Up1.75%

Allergan Inc. (AGN)

-NYSE
184.95 Up 5.70(3.18%) 11:37AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 6,300,400   5,646,600   5,216,000  
Cost of Revenue795,800  751,200  718,000  
Gross Profit 5,504,600   4,895,400   4,498,000  
Operating Expenses
Research Development1,042,300  977,300  871,500  
Selling General and Administrative2,519,400  2,193,100  2,158,300  
Non Recurring16,900  23,800  7,500  
Others116,700  90,200  86,100  
Total Operating Expenses3,695,300  3,284,400  3,123,400  
Operating Income or Loss 1,809,300   1,611,000   1,374,600  
Income from Continuing Operations
Total Other Income/Expenses Net(3,500)(16,400)6,400  
Earnings Before Interest And Taxes1,805,800  1,594,600  1,381,000  
Interest Expense75,000  63,600  71,800  
Income Before Tax1,730,800  1,531,000  1,309,200  
Income Tax Expense458,300  430,300  359,600  
Minority Interest(3,600)(3,700)(3,600)
Net Income From Continuing Ops1,272,500  1,100,700  949,600  
Non-recurring Events
Discontinued Operations(283,800)1,800  (11,500)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 985,100   1,098,800   934,500  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 985,100   1,098,800   934,500  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.